| #215 |
Meng-Yun Sandy Chou |
— |
1 |
| #215 |
Patrick Egbuchulam |
Visa |
1 |
| #215 |
Rhohei Hinokuma |
— |
1 |
| #215 |
Michael Ramsey |
Salesforce |
1 |
| #215 |
Peter Kelley Sheerin |
Intel |
1 |
| #215 |
Leena Sampemane |
Intuit |
1 |
| #215 |
Hitoshi Harada |
Emc Ip Holding Company |
1 |
| #215 |
Gang Song |
Google |
1 |
| #215 |
Mingchen Zhao |
Meta |
1 |
| #215 |
Michael P. Arend |
Fibrogen |
1 |
| #215 |
Hartmut Vogler |
Sap Ag |
1 |
| #215 |
Kapil Kumar Karki |
Gilead Sciences |
1 |
| #215 |
Basudeb Ghosh |
Visa |
1 |
| #215 |
Tomas Alabes |
Oracle |
1 |
| #215 |
Chun Hok Ho |
Sk Hynix |
1 |
| #215 |
Marc T. Dunham |
Analog Devices |
1 |
| #215 |
Shichang Miao |
Chemocentryx |
1 |
| #215 |
Jaeson Caulley |
Document Security Systems |
1 |
| #215 |
Seth Luisi |
Sony |
1 |
| #215 |
Achim Karger |
Thermo Fisher |
1 |
| #215 |
Henry Pang |
Nikon |
1 |
| #215 |
Wolin Huang |
Portola Pharmaceuticals |
1 |
| #215 |
Philip Hui |
Kci Licensing |
1 |
| #215 |
Marc Batchan |
Visa |
1 |
| #215 |
Justin Moravetz |
Sony |
1 |
| #215 |
Oleksandr Khimich |
Google |
1 |
| #215 |
Aniket Kale |
Heliae Development |
1 |
| #215 |
Feng Jin |
Gilead Sciences |
1 |
| #215 |
Diego C. Hernandez |
Apple |
1 |
| #215 |
Yan Zhang |
Zynga |
1 |
| #215 |
Marc Cleven |
Visa |
1 |
| #215 |
George Dimitrios Fanourgiakis |
Unknown |
1 |
| #215 |
Zhongxu Ren |
Nektar Therapeutics |
1 |
| #215 |
Neha Singh |
PayPal |
1 |
| #215 |
Parag Avinash Namjoshi |
Workday |
1 |
| #215 |
Bhavani Subramaniam |
Walmart Apollo |
1 |
| #215 |
Jeff Tillack |
Credence Medsystems |
1 |
| #215 |
Joshua A. Kaplan |
Gilead Sciences |
1 |
| #215 |
Daniel Haight |
Yahoo Assets |
1 |
| #215 |
Mike Kinney |
Icontrol Networks |
1 |
| #215 |
Wei-Ching Liang |
Genentech |
1 |
| #215 |
Parveen Bansal |
Visa |
1 |
| #215 |
David Lin |
Veritas Technologies |
1 |
| #215 |
Ketki Ashok Dhamnaskar |
Ra Pharmaceuticals |
1 |
| #215 |
Mark A. Collins |
View |
1 |
| #215 |
Sayeed Mohammed |
Visa |
1 |
| #215 |
Phaneendra Ramaseshu Lingappa |
Visa |
1 |
| #215 |
Chingwei V. Lee |
Genentech |
1 |
| #215 |
Philip James Dolan, III |
Prothena Biosciences Limited |
1 |
| #215 |
Energy Cruse, II |
Intuitive Surgical |
1 |